These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 22302316

  • 21. Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody.
    Mikuls TR, O'Dell JR, Stoner JA, Parrish LA, Arend WP, Norris JM, Holers VM.
    Arthritis Rheum; 2004 Dec; 50(12):3776-82. PubMed ID: 15593224
    [Abstract] [Full Text] [Related]

  • 22. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
    Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ.
    Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
    [Abstract] [Full Text] [Related]

  • 23. Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis.
    Rojas-Villarraga A, Diaz FJ, Calvo-Páramo E, Salazar JC, Iglesias-Gamarra A, Mantilla RD, Anaya JM.
    J Autoimmun; 2009 Feb; 32(1):64-9. PubMed ID: 19117726
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.
    van der Woude D, Young A, Jayakumar K, Mertens BJ, Toes RE, van der Heijde D, Huizinga TW, van der Helm-van Mil AH.
    Arthritis Rheum; 2009 Aug; 60(8):2262-71. PubMed ID: 19644846
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
    Vallbracht I, Rieber J, Oppermann M, Förger F, Siebert U, Helmke K.
    Ann Rheum Dis; 2004 Sep; 63(9):1079-84. PubMed ID: 15308516
    [Abstract] [Full Text] [Related]

  • 26. Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry.
    Gottenberg JE, Ravaud P, Cantagrel A, Combe B, Flipo RM, Schaeverbeke T, Houvenagel E, Gaudin P, Loeuille D, Rist S, Dougados M, Sibilia J, Le Loët X, Marcelli C, Bardin T, Pane I, Baron G, Mariette X.
    Ann Rheum Dis; 2012 Nov; 71(11):1815-9. PubMed ID: 22615458
    [Abstract] [Full Text] [Related]

  • 27. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O.
    Arthritis Rheum; 2006 Feb 15; 55(1):53-6. PubMed ID: 16463412
    [Abstract] [Full Text] [Related]

  • 28. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.
    Cambridge G, Leandro MJ, Edwards JC, Ehrenstein MR, Salden M, Bodman-Smith M, Webster AD.
    Arthritis Rheum; 2003 Aug 15; 48(8):2146-54. PubMed ID: 12905467
    [Abstract] [Full Text] [Related]

  • 29. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
    Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ.
    Arthritis Rheum; 2003 Oct 15; 48(10):2741-9. PubMed ID: 14558078
    [Abstract] [Full Text] [Related]

  • 30. Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy.
    de Man YA, Bakker-Jonges LE, Goorbergh CM, Tillemans SP, Hooijkaas H, Hazes JM, Dolhain RJ.
    Ann Rheum Dis; 2010 Feb 15; 69(2):420-3. PubMed ID: 19282308
    [Abstract] [Full Text] [Related]

  • 31. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
    Solanki K, Spellerberg M, Chapman P, Moller P, O'Donnell J.
    N Z Med J; 2004 Oct 08; 117(1203):U1097. PubMed ID: 15477921
    [Abstract] [Full Text] [Related]

  • 32. Intraarticular corticosteroid injection in the management of children with chronic arthritis.
    Padeh S, Passwell JH.
    Arthritis Rheum; 1998 Jul 08; 41(7):1210-4. PubMed ID: 9663477
    [Abstract] [Full Text] [Related]

  • 33. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S.
    J Rheumatol; 2006 Dec 08; 33(12):2390-7. PubMed ID: 16924694
    [Abstract] [Full Text] [Related]

  • 34. Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
    Jensen TW, Hansen MS, Hørslev-Petersen K, Hyldstrup L, Abrahamsen B, Langdahl B, Zerahn B, Pødenphant J, Stengaard-Petersen K, Junker P, Østergaard M, Lottenburger T, Ellingsen T, Andersen LS, Hansen I, Skjødt H, Pedersen JK, Lauridsen UB, Svendsen AJ, Tarp U, Lindegaard H, Jurik AG, Vestergaard A, Hetland ML, Cimestra study group.
    Ann Rheum Dis; 2014 Jun 08; 73(6):1123-9. PubMed ID: 23661492
    [Abstract] [Full Text] [Related]

  • 35. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A, Plischke H, Kellner H, Gruber R.
    Ann N Y Acad Sci; 2005 Jun 08; 1050():295-303. PubMed ID: 16014545
    [Abstract] [Full Text] [Related]

  • 36. Value of ultrasonography for diagnosis of synovitis associated with rheumatoid arthritis.
    Xiao H, Liu M, Tan L, Liao X, Li Y, Gao J, Li F, Xie X, Peng Q, Mao N, Tian J, Du J, Chen J.
    Int J Rheum Dis; 2014 Sep 08; 17(7):767-75. PubMed ID: 24863714
    [Abstract] [Full Text] [Related]

  • 37. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
    Iwamoto N, Kawakami A, Tamai M, Fujikawa K, Arima K, Aramaki T, Kawashiri S, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Eguchi K.
    J Rheumatol; 2009 Jan 08; 36(1):113-5. PubMed ID: 19132785
    [Abstract] [Full Text] [Related]

  • 38. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafström I.
    Arthritis Rheum; 2005 Nov 08; 52(11):3360-70. PubMed ID: 16255010
    [Abstract] [Full Text] [Related]

  • 39. Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.
    Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U, Gabay C, van Riel PL, Nordström DC, Gomez-Reino J, Pavelka K, Tomsic M, Kvien TK, van Vollenhoven RF.
    Ann Rheum Dis; 2011 Sep 08; 70(9):1575-80. PubMed ID: 21571731
    [Abstract] [Full Text] [Related]

  • 40. Magnetic resonance imaging: a valuable method for the detection of synovial inflammation in rheumatoid arthritis.
    Goupille P, Roulot B, Akoka S, Avimadje AM, Garaud P, Naccache L, Le Pape A, Valat JP.
    J Rheumatol; 2001 Jan 08; 28(1):35-40. PubMed ID: 11196540
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.